Therapeutic ReviewsComorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A ReviewGarakani, Amir1; Win, Terrance1; Virk, Subhdeep1; Gupta, Sanjay2; Kaplan, David3; Masand, Prakash S. *Author Information 1Department of Psychiatry, Mt. Sinai School of Medicine, New York, NY; 2Olean General Hospital, Olean, New York; 3Syracuse Gastroenterological Associates, Syracuse, New York; and 4Department of Psychiatry, Duke University Medical Center, Durham, North Carolina. *Address for correspondence: Box 3391, Duke University Medical Center, Durham, NC 27710, U.S.A.; e-mail: [email protected] American Journal of Therapeutics: January-February 2003 - Volume 10 - Issue 1 - p 61-67 Buy Abstract Irritable bowel syndrome (IBS), a functional gastrointestinal disorder, is present in 10% to 20% of the U.S. adult population. The syndrome is best defined as chronic abdominal discomfort with changes in stool frequency, consistency, and passage, with associated symptoms such as abdominal bloating or presence of mucus in stools. Several studies have shown that up to 70% to 90% of patients with IBS who seek treatment have psychiatric comorbidity, most notably mood and anxiety disorders. Recent studies have shown a high prevalence of IBS in psychiatric patients who seek treatment, with a prevalence of 19% in schizophrenia, 29% in major depression, and 46% in panic disorder among other disorders. Our article reviews the comorbidity of IBS in psychiatric patients and discusses implications for treatment. © 2003 Lippincott Williams & Wilkins, Inc.